 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Initial Public Offering of Plethico Pharmaceuticals Ltd has received tremendous response from investors with the issue getting oversubscribed by 22.93 times. Plethico Pharmaceuticals Ltd came out with a Initial Public Offering of equity shares of Rs.10 each for cash at a price band of Rs.280 to Rs.300 per share. The issue consists of 3,666,666 equity shares Rs.10/- each aggregating Rs.110 Crores.
The issue opened on April 10, 2006 and closed today. The Qualified Institutional Buyers (QIBs) portion of the issue received subscription for 23.6339 times, Non Institutional Investors portion 42.8463 times and the Retail Individual Investors (RIIs) portion of the issue received subscription for 18.2037 times. The issue received an overall subscription of 23.93 times.